510(k) Report

De Novo · Granted

Granted

Cellsearch Epithelial Cell Enrichment Kit; Cellspotter System

DEN040001De NovoGranted Jan 21, 200419-day reviewClass II21 CFR 866.6020

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Advanced Diagnostic Systems · NQI System, Immunomagnetic, Circulating Cancer Cell, Enumeration

Granted on Jan 21, 2004 as a new device type through De Novo after a 19-day review. 10 later devices descend from it.

Decided
Jan 21, 2004
Review
19 days
Class
Class II
Product code
NQI
Recalls
None

10 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2005: 2 descendants cleared2004: 1 descendant cleared2006: 2 descendants cleared2011: 1 descendant cleared2007: 1 descendant cleared2008: 1 descendant cleared2013: 1 descendant cleared2010: 1 descendant cleared200020052010201520202025
  1. This deviceDEN040001 Cellsearch Epithelial Cell Enrichment Kit; Cellspotter SystemAdvanced Diagnostic Systems · 2004
  2. Descendant · cites it directly · 4 of its ownK050245 Cellsearch Circulating Tumor Cell KitVeridex, LLC · 2005 · Recalled
  3. Descendant · 2 generations on · 3 of its ownK062013 Cellsearch Circulating Tumor Cell KitVeridex, LLC · 2006 · Recalled
  4. Descendant · cites it directly · 3 of its ownK050145 Celltracka Analyzer IIImmunicon Corp. · 2005 · Recalled
  5. Descendant · 3 generations on · 2 of its ownK071729 Cellsearch Circulating Tumor Cell KitVeridex, LLC · 2007
  6. Descendant · 2 generations on · 2 of its ownK060110 Celltracks Analyzer IIImmunicon Corp. · 2006 · Recalled

Showing 5 of 10 descendants. See all descendants

Descendants cleared per year

2004: 12005: 22006: 22007: 12008: 12010: 12011: 12013: 1
2004high 2 (2005) · low 0 (2009)2026

Most influential descendants

Showing 5 of 10 · See all
  • K050245Cellsearch Circulating Tumor Cell KitVeridex, LLC · 2005 · cites it directly4descendants
  • K062013Cellsearch Circulating Tumor Cell KitVeridex, LLC · 2006 · 2 generations on3descendants
  • K050145Celltracka Analyzer IIImmunicon Corp. · 2005 · cites it directly3descendants
  • K071729Cellsearch Circulating Tumor Cell KitVeridex, LLC · 2007 · 3 generations on2descendants
  • K060110Celltracks Analyzer IIImmunicon Corp. · 2006 · 2 generations on2descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN040001Cellsearch Epithelial Cell Enrichment Kit; Cellspotter SystemAdvanced Diagnostic Systems2004—
+1K050245Cellsearch Circulating Tumor Cell KitVeridex, LLC20051
+2K062013Cellsearch Circulating Tumor Cell KitVeridex, LLC20061
+1K050145Celltracka Analyzer IIImmunicon Corp.20052
+3K071729Cellsearch Circulating Tumor Cell KitVeridex, LLC2007—
+2K060110Celltracks Analyzer IIImmunicon Corp.20061

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200520
200620
200710
200810
201010
201110
201310
FIG. 1 — Lineage of DEN040001, 2004–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NQI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (10)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K050245Cellsearch Circulating Tumor Cell KitVeridex, LLC20054
K050145Celltracka Analyzer IIImmunicon Corp.20053
K040898Cellsearch Epithelial Cell Control KitVeridex, LLC20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K050245 (Veridex, LLC, 2005) has gone furthest, with 4 descendants of its own.

How does its category compare?

All NQI devices

NQI System, Immunomagnetic, Circulating Cancer Cell, Enumeration: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NQI

1in 2013

2007: 12008: 12010: 12011: 12012: 22013: 1
2007high 2 (2012) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NQI

Too few NQI 510(k)s in any year since 2007 to give a median.

Recalls per year · NQI

1in 2011

2007: 12009: 12011: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NQI

3in 2008

2008: 3
2007high 3 (2008) · low 0 (2007)2025

MAUDE reports naming product code NQI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—10
20081—03
20090—10
20101—00
20111—10
20122—00
20131—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “DEN040001: Cellsearch Epithelial Cell Enrichment Kit; Cellspotter System.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/DEN040001

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026